NIHR Maudsley BRC Blog

Our latest news & events

COVID-19 variant vaccine begins recruiting in south London

Volunteers in south London are being asked to take part in a study using an Oxford/AstraZeneca variant vaccine, aimed at preventing the Beta COVID-19 variant.

By NIHR King's Clinical Research Facility at 7 Jul 2021

Global ALS/MND recognition Day

Today, Monday 21st of June, marks the Global Day of Recognition for AMD/MND. To mark this, we discuss MND research happening at the King's CRF with Lead Research Nurse Theresa and a participant on one of the trials.

By NIHR King's Clinical Research Facility at 17 Jun 2021

Latest COVID-19 Vaccine Study in the UK Launches in London

On Wednesday 14th April, the latest COVID-19 vaccine study was launched in London, with the King's Clinical Research Facility being one of the sites taking part. Sponsored by Canadian biopharmaceutical company Medicago and GlaxoSmithKline, the Phase 3 clinical trial will test the safety and efficacy of a plant-derived vaccine candidate named CoVLP.

By NIHR King's Clinical Research Facility at 14 Apr 2021

Novavax confirms vaccine provides 100% protection against severe COVID-19

Final analysis of UK Phase 3 trials of Novavax's COVID-19 vaccine reveals it provides 100% protection against severe COVID-19.

By NIHR Wellcome King's Clinical Research Facility at 16 Mar 2021

Professor Peter Goadsby awarded world’s top Brain Prize 2021

Peter Goadsby, Professor of Neurology at King's College London’s Institute of Psychiatry, Psychology & Neuroscience (IoPPN), and Director at the National Institute for Health Research-Wellcome Trust Clinical Research Facility (NIHR CRF), King's College Hospital has been awarded the world’s top Brain Prize from the Lundbeck Foundation for his pioneering migraine research.

By NIHR Maudsley BRC at 4 Mar 2021